[go: up one dir, main page]

SU1367487A1 - Rabies vaccine production method - Google Patents

Rabies vaccine production method

Info

Publication number
SU1367487A1
SU1367487A1 SU4017807/13A SU4017807A SU1367487A1 SU 1367487 A1 SU1367487 A1 SU 1367487A1 SU 4017807/13 A SU4017807/13 A SU 4017807/13A SU 4017807 A SU4017807 A SU 4017807A SU 1367487 A1 SU1367487 A1 SU 1367487A1
Authority
SU
USSR - Soviet Union
Prior art keywords
virus
production method
inactivated
vaccine production
rabies vaccine
Prior art date
Application number
SU4017807/13A
Other languages
Russian (ru)
Inventor
Т.А. Аксенова
Л.Б. Эльберт
М.А. Селимов
И.В. Красильников
Л.И. Кротова
Л.Ф. Грибенча
Original Assignee
Институт полиомиелита и вирусных энцефалитов АМН СССР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт полиомиелита и вирусных энцефалитов АМН СССР filed Critical Институт полиомиелита и вирусных энцефалитов АМН СССР
Priority to SU4017807/13A priority Critical patent/SU1367487A1/en
Application granted granted Critical
Publication of SU1367487A1 publication Critical patent/SU1367487A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

FIELD: microbiological industry. SUBSTANCE: method involves cell culturing of Vnukovo-32 rabies virus strain. The virus-containing liquid is collected and inactivated by sequential exposure to UV- radiation and formaldehyde solution. The inactivated virus is concentrated and purified by means of ultrafiltration with the use of porous membranes and gel-filtration on porous silicon dioxide modified with polyvinyl pyrrolidon. EFFECT: higher product purity; higher reliability of inactivation. 2 cl, 2 tbl
SU4017807/13A 1986-01-29 1986-01-29 Rabies vaccine production method SU1367487A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4017807/13A SU1367487A1 (en) 1986-01-29 1986-01-29 Rabies vaccine production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4017807/13A SU1367487A1 (en) 1986-01-29 1986-01-29 Rabies vaccine production method

Publications (1)

Publication Number Publication Date
SU1367487A1 true SU1367487A1 (en) 1995-10-27

Family

ID=60535168

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4017807/13A SU1367487A1 (en) 1986-01-29 1986-01-29 Rabies vaccine production method

Country Status (1)

Country Link
SU (1) SU1367487A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA010428B1 (en) * 2004-05-27 2008-08-29 Бакстер Интернэшнл Инк. Inactivation of a pathogen in a sample by a treatment with formalin and uv light
US8703467B2 (en) 2004-05-27 2014-04-22 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and UV light

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA010428B1 (en) * 2004-05-27 2008-08-29 Бакстер Интернэшнл Инк. Inactivation of a pathogen in a sample by a treatment with formalin and uv light
US8703467B2 (en) 2004-05-27 2014-04-22 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and UV light

Similar Documents

Publication Publication Date Title
AU2051888A (en) Novel process for purification of hepatitis a virions
FI931274A (en) Process for Preparation of Purified Glycolipids Using Membrane Separation Process
GR3005297T3 (en)
Pay et al. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process
IT1066729B (en) PROCEDURE FOR THE PRODUCTION OF ULTRAFILTRATION MEMBRANES CONTAINING ACTIVE REACTION CENTERS AND PRODUCT OBTAINED
ATE7855T1 (en) PRODUCTION OF VIRUS ANTIGENS.
FI812560L (en) FRAMEWORK FOR IMMOBILIZATION OF IMMOBILIZERS (6-0-ALPHA-D-GLUCOPYRANOSID-D-FRUCTOS)
ES8104405A1 (en) Influenza virus vaccines, process for preparing them and process for propagating influenza viruses.
DE3884680D1 (en) Outer membrane protein F from Pseudomonas aeruginosa.
DK617386A (en) METHOD OF PREPARING 2-KETO-D-GLUCARIC ACID
SU1367487A1 (en) Rabies vaccine production method
DK125887A (en) PROTECTION OF HORSES AGAINST STREPTOCOCCUS EQUI
KR0163175B1 (en) Improved enzymatic oxidation of ceph-c to glutaryl-7-amino-cephalosporanic acid
GB1413614A (en) Virus production
AU7009387A (en) Membrane proteoglycans ribosomal vaccines
ES8306021A1 (en) Method for concentrating beta-lactam antibiotic solution.
GB1446107A (en) Production of vaccines
JPS54132291A (en) Novel bioreactor
WO1987007640A1 (en) Process for preparing neuraminidase
GB1179523A (en) Enzyme Purification Process
ITMI913375A1 (en) PROCEDURE FOR THE PRODUCTION OF NEURAMINIDASE
FR2290220A2 (en) NEW ANTIRABIC VACCINE
JPS5489088A (en) Preparation of d-alpha-amino acid
JPS5452791A (en) Preparation of d-alpha-amino acid
GB890618A (en) Antigenic material from brucella and method of preparing same

Legal Events

Date Code Title Description
REG Reference to a code of a succession state

Ref country code: RU

Ref legal event code: MM4A

Effective date: 20030130